Particularly, 68 Ga-labeled fibroblast-activation protein inhibitor (68 Ga-FAPI) demonstrated significant uptake in IDH-wildtype GBM and grade III and IV IDH-mutant gliomas [48]. The gene discussed is IDH1; the disease is central nervous system cancer.